Neumora Therapeutics Inc. News
Latest updates and market news for NMRA
6 news
Jan 3 - Jan 9, 2026
Page 1
MT Newswires
Mizuho Adjusts Price Target on Neumora Therapeutics to $6 From $5, Maintains Outperform Rating
📊
AI Sentiment
Positive
7/10
GlobeNewswire
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
RBC Sees Upside Potential in Neumora Therapeutics (NMRA)
📈
AI Sentiment
Highly Positive
8/10
Share this news page